•  
  •  
  •  
  •  

2025-10-01 21:03:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  ShukraPharmaceuticals

Stock Report

  • Shukra Pharmaceuticals Ltd inks Strategic PAN India Distribution tie-up with Wockhardt Limited
  • Shukra Pharmaceuticals Ltd awarded contract by HSCC India Ltd
  • Shukra Pharmaceuticals Ltd receives LoA from RMSCL
  • Shukra Pharmaceuticals Ltd fixes Mar 21, 2025 as record date for 10 For 1 Stock Split
  • Shukra Pharmaceuticals Ltd recommends 3:1 bonus issue
  • Shukra Pharmaceuticals Ltd Q1FY24 net profit plunges QoQ to Rs. 42.03 lakhs
  • Shukra Pharmaceuticals Ltd fixes Feb 2, 2023 as record date for rights issue
  • Shukra Pharmaceuticals Ltd board approves rights issue
  • Shukra Pharmaceuticals Ltd Q1FY23 net profit slides QOQ to Rs. 32.79 lakhs
  • Shukra Pharmaceuticals Ltd Q4FY22 PAT higher at Rs. 64.69 lakhs
  • Shukra Pharmaceuticals Ltd recommends final dividend of Rs. 0.50
  • Shukra Pharmaceuticals Q3FY22 net profit at Rs. 4.80 lakhs
  • Shukra Pharmaceuticals Ltd Q2FY22 net profit at Rs. 1.92 lakhs

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024